Among the costs incurred by pharmaceutical companies worldwide when producing innovative healthcare solutions and drugs, the costs of pharmacovigilance tests, projects, and reports always rank the highest. From interpreting the results from ICSR processing to running PADER and managing adverse events post-marketing or post-clinical trials, the task of pharmacovigilance is always a challenge for big pharma companies and SME’s in pharmaceutical industry.